10 Oct 2012
The results of their study show that HDAC5 regulates glucose metabolism and insulin action in both human and mouse myotubes. They also showed that HDAC inhibition in myotubes could increase glucose uptake and basal energy expenditure. As glucose metabolism is dysregulated in metabolic disease states such as obesity and type 2 diabetes, these data indicate that further experiments targeting HDAC5 as a therapeutic strategy for the treatment of these diseases are needed. Raichur et al. (2012) Journal of Molecular Endocrinology 49 203-211.
Read full article at: DOI: 10.1530/JME-12-0095
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024